| Authors: |
MacDonald LP; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kypriotakis G; Department of Behavioral Science, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Karam-Hage M; Department of Behavioral Science, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Minnix JA; Department of Behavioral Science, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Beneventi D; Department of Behavioral Science, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Cui Y; Department of Behavioral Science, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Blalock JA; Department of Behavioral Science, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Robinson JD; Department of Behavioral Science, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Alhalabi O; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Hassanazadeh CJ; Department of Genitourinary Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lee BH; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Navai N; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kamat AM; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Dinney CP; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Cinciripini PM; Department of Behavioral Science, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Bree KK; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: kbree@mdanderson.org. |